25.01.2016 Views

Chapter 86

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

1448 PART 5 ■ Anesthetic, Surgical, and Interventional Procedures: Considerations<br />

TABLE <strong>86</strong>-8. Reference Values (Mean [Boundary]) for Coagulation Tests in Term and Premature (30–36 g.w.) Babies<br />

Coagulation test Day 1 Day 5 Day 30 Adult<br />

Premature infants<br />

PT (sec) 13.0 (10.6–16.2) 12.5 (10.0–15.3) 11.8 (10.0–13.6) 12.4 (10.8–13.9)<br />

APTT (sec) 53.6 (27.5–79.4) 50.5 (26.9–74.1) 44.7 (26.9–62.5) 33.5 (26.6–40.3)<br />

TCT (sec) 24.8 (19.2–30.4) 24.1 (18.8–29.4) 24.4 (18.8–29.9) 25.0 (19.7–30.3)<br />

Fibrinogen (g/L) 2.43 (1.50–3.73) 2.80 (1.60–4.18) 2.54 (1.50–4.14) 2.78 (1.56–4.00)<br />

Coagulation inhibitors<br />

AT III (U/mL) 0.38 (0.14–0.62) 0.56 (0.30–0.82) 0.59 (0.37–0.81) 1.05 (0.79–1.31)<br />

Protein C (U/mL) 0.28 (0.12–0.44) 0.31 (0.11–0.51) 0.37 (0.15–0.59) 0.96 (0.64–1.28)<br />

Term infants<br />

PT (sec) 13.0 (10.1–15.9) 12.4 (10.0–15.3) 11.8 (10.0–14.3) 12.4 (10.8–13.9)<br />

APTT (sec) 42.9 (31.3–54.5) 42.6 (25.4–59.8) 40.4 (32.0–55.2) 33.5 (26.6–40.3)<br />

TCT (sec) 23.5 (19.0–28.3) 23.1 (18.0–29.2) 24.3 (19.4–29.2) 25.0 (19.7–30.3)<br />

Fibrinogen (g/L) 2.83 (1.67–3.99) 3.12 (1.62–4.62) 2.70 (1.62–3.78) 2.78 (1.56–4.00)<br />

Coagulation inhibitors<br />

AT III (U/mL) 0.63 (0.39–0.87) 0.67 (0.41–0.93) 0.78 (0.48–1.08) 1.05 (0.79–1.31)<br />

Protein C (U/mL) 0.35 (0.17–0.53) 0.50 (0.22–0.78) 0.63 (0.33–0.93) 0.96 (0.64–1.28)<br />

PT prothrombin time; APTT activated partial thromboplastin time; TCT thrombin clotting time; AT III antithrombin III.<br />

Adapted from Andrew et al. 144<br />

When major surgery is planned a preoperative coagulation screen<br />

consisting of prothrombin time, activated partial thromboplastin<br />

time, and platelet count should be performed before surgery.<br />

The use of thromboelastography has recently been described<br />

also in neonates and infants. Using this technique, children with<br />

complex congenital heart disease have been found to have a<br />

functionally intact coagulation-fibrinolytic system working at a<br />

lower level than in healthy infants, indicating a reduction in the<br />

hemostatic potential with less reserve. 97 Using the same techno -<br />

logy, the effects of various colloid alternatives were analyzed in<br />

infants (3–15 kg). 98 In this investigation, the use of gelatins as an<br />

alternative to albumin was suggested since the use of hydroxyethyl<br />

starch affected the overall coagulation process the most.<br />

Diagnostic Investigations<br />

Special investigations can be required after taking the medical<br />

history and obtaining results from the laboratory testing. The most<br />

common preoperative investigations are chest radiography,<br />

echocardiography and ultrasonic head scans.<br />

Chest X-Rays<br />

Chest radiographs should be obtained in all patients with cardio -<br />

respiratory symptoms. Not only will this investigation provide the<br />

anesthesiologist with information regarding the severity of various<br />

conditions but it can also provide information if further treatment<br />

might optimize the patients condition before anesthesia and<br />

surgery. Thus, based on the chest radiograph, surgery might be<br />

postponed in order to re-expand atelectatic lung tissue or to<br />

reduce interstitial edema by intensifying diuretic treatment.<br />

Ultrasonographic Examinations<br />

Echocardiography should be performed liberally not only to search<br />

for associated congenital heart disease but also to more precisely<br />

estimate the intravascular volume status. Echocardiography is also<br />

useful in order to determine if the ductus arteriosus still remains<br />

open and to determine the possible presence of pulmonary<br />

hypertension and right-to-left shunting.<br />

Due to the existence of an open fontanel ultrasonic head scans<br />

provide the unique opportunity for investigating the intracranial<br />

contents of the neonate (for the vein of Galen for instance). In<br />

term neonates, this investigation rarely provides crucial infor -<br />

mation since intracranial hemorrhage is unusual in this group.<br />

However, premature infants have an increased risk for such<br />

hemorrhages with the highest risk seen in the most prematurely<br />

born babies. Before performing anesthesia in such premature<br />

infants, it might be wise to perform an ultrasonic head scan in<br />

order to document any pre-existing problem and, thus, escape the<br />

responsibility for any hemorrhages which have already occurred<br />

prior to the involvement of the anesthesiologist. 99<br />

PREANESTHETIC MANAGEMENT<br />

Premedication<br />

If the neonate is judged to be in pain preoperatively, low and<br />

titrated doses of morphine are appropriate. The response to<br />

morphine in this age group is variable and doses of 10 to 20 g/kg<br />

should be administered intravenously until adequate pain relief is<br />

achieved. In case of difficult venous access where an inhalational<br />

induction is planned, subcutaneous or intramuscular atropine<br />

(10–20 g/kg; minimum 100 g) is often useful to counteract<br />

parasympathetic reflexes before the placement of a reliable venous<br />

line. In case of intravenous induction, atropine can be given<br />

intravenously (10 g/kg; minimum 100 g) just before the start of<br />

the anesthetic. Apart from these specific situations, no preme -<br />

dication is usually required in the neonatal period.<br />

Parental Presence During Induction<br />

In older patients, parental presence can be helpful, although cer -<br />

tain practitioners still find this practice questionable. 100,101<br />

However, the neonate is not yet mentally capable of psychologic -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!